1 Individualized Assessment for Percutaneous or
Surgical-Based Revascularization
2 Evidence-Based Interventional Practice
3 Diabetes
4 Noninvasive Evaluation: Functional Testing,Multidetector
Computed Tomography, and Stress Cardiac MRI
5 Intracoronary Pressure and Flow Measurements
6 Contrast-Induced Acute Kidney Injury and the Role of
Chronic Kidney Disease in Percutaneous Coronary Intervention
7 Radiation Safety During Cardiovascular Procedures
8 Coronary and Valvular Intervention Prior to
Noncardiac Surgery
9 Sex and Ethnicity Issues in Interventional
Cardiology
10 Platelet Inhibitor Agents
11 Anticoagulation in Percutaneous Coronary
Intervention
12 Thrombolytic Intervention
13 Other Adjunctive Drugs for Coronary Intervention:
Beta-Blockers, Calcium-Channel Blockers, and Angiotensin-Converting
Enzyme Inhibitors
14 Coronary Stenting: Practical Considerations,
Equipment Selection, Tips and Caveats
15 Coronary Stenting
16 Bioresorbable Coronary Scaffolds
17 Drug-Eluting Balloons
18 Elective Intervention for Stable Angina or Silent
Ischemia
19 Intervention for Non-ST-Segment Elevation Acute Coronary
Syndromes
20 Percutaneous Coronary Intervention in Acute
ST-Segment Elevation Myocardial Infarction
21 Post-Percutaneous Coronary Intervention Hospitalization,
Length of Stay, and Discharge Planning
22 Interventions in Cardiogenic Shock
23 Bifurcations and Branch Vessel Stenting
24 Percutaneous Coronary Intervention for Unprotected
Left Main Coronary Artery Stenosis
25 Complex and Multivessel Percutaneous Coronary
Intervention
26 Intervention for Coronary Chronic Total
Occlusions
27 Bypass Graft Intervention
28 The Thrombus-Containing Lesion
29 Complications of Percutaneous Coronary
Intervention
30 Periprocedural Myocardial Infarction and
Embolism-Protection Devices
31 Access Management and Closure Devices
32 Transradial Access for Cardiovascular
Catheterization and Intervention
33 Role of the Cardiac Surgeon and the Heart Team
34 Restenosis
35 Role of Adjunct Devices: Atherectomy, Cutting Balloon, and
Laser
36 Supported Percutaneous Intervention
37 Regional Centers of Excellence for the Care of Patients
With Acute Ischemic Heart Disease
38 Diagnosis and Treatment of Coronary Microvascular
Disease
39 Lower Extremity Interventions
40 Upper Extremities and Aortic Arch
41 Chronic Mesenteric Ischemia: Diagnosis and
Intervention
42 Renal Artery Stenosis
43 Device Therapy for Resistant Hypertension
44 Aortic Vascular Interventions (Thoracic and
Abdominal)
45 Venous Intervention
46 Carotid and Cerebrovascular Intervention
47 Stroke Centers and Interventional Cardiology
48 Imaging for Intracardiac Interventions
49 Percutaneous Closure of Patent Foramen Ovale and Atrial
Septal Defect
50 Left Atrial Appendage Closure and Stroke: Local
Device Therapy for Cardioembolic Stroke Protection
51 Mitral Valvuloplasty
52 Percutaneous Mitral Valve Repair and Replacement
53 Balloon-Expandable Transcatheter Aortic Valve
Replacement Systems
54 Self-Expanding Transcatheter Aortic Valve
Replacement
55 Percutaneous Transcatheter Valve-in-Valve
Implantation
56 Pulmonary Valve Interventions
57 Percutaneous Tricuspid Valve Repair
58 Hypertrophic Cardiomyopathy
59 Percutaneous Balloon Pericardiotomy for Patients With
Pericardial Effusion and Tamponade
60 Transcatheter Therapies for Congenital Heart
Disease
61 Stem Cell Therapy for Ischemic Heart Disease
62 Percutaneous Treatment of Paravalvular Leak
63 Interventional Heart Failure
64 Qualitative and Quantitative Coronary
Angiography
65 Intravascular Ultrasound
66 The Dynamic Spectrum of Coronary Atheroma: From
Atherogenesis to Vulnerable Plaque to Plaque Regression
67 Optical Coherence Tomography
68 Medical Economics in Interventional Cardiology
69 Quality of Care in Interventional Cardiology
70 Volume and Outcome
Eric Topol is one of the most influential cardiologists and
scientists in the world, a true "rock star in cardiology. He is
internationally known due to his serving as Editor-in-Chief of
Medscape, his numerous multi-million dollar ground-breaking NIH
research studies, his widely adopted medical innovations, and his
frequent appearances on broadcast television. He is the founding
director of the Scripps Translational Institute where large
multidisciplinary teams investigate medical innovations in
practice, research, and education for the future of medicine.
Because of Dr Topol's incredibly busy schedule and the fact that Dr
Teirstein acted as lead editor on the current edition, Dr Topol has
proposed a succession plan for the revision, with his colleague Dr
Teirstein officially lead editor and the addition of their
colleague Dr Price as a second new editor, and a title change from
Textbook of Interventional Cardiology to Topol's Textbook of
Interventional Cardiology. Paul Teirstein, MD, is Chief of
Cardiology, Director of Interventional Cardiology, and Medical
Director at the Scripps Prebys Cardiovascular Institute/Scripps
Clinic in La Jolla, California.
![]() |
Ask a Question About this Product More... |
![]() |